Riskpilot← Back to searchSign inGet full accessVM79 hälsa och sjukvård AB
ABActiveOrg 5591737423Indalsbacken 2General medical practice activities · NACE 8621Est. 20181-4 employees
Revenue 2024
SEK 16,9M
-1% vs 2023
EBITDA margin
36.9%
0% vs 2023
Equity ratio
43.4%
Financial strength
Net profit 2024
SEK 5,1M
+69% vs 2023
| Revenue | SEK 16,9M | -1% |
| EBITDA | SEK 6,2M | +0% |
| Net profit | SEK 5,1M | +69% |
| Total assets | SEK 17M | +32% |
| Equity | SEK 7,4M | +41% |
| Employees | — | — |
Legal name
VM79 hälsa och sjukvård AB
Org number
5591737423
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 oktober 2018
Share capital
SEK 50 000
Employees
1-4
VAT registered
No
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget kommer vara verksamt inom Hälso- och sjukvård
Address
Indalsbacken 2
Email
silvnas_kjell@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12 069 | 14 839 | 14 419 | 17 169 | 16 931 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 136 | 5 948 | 3 305 | 6 270 | 6 243 |
| Depreciation & amort. | −94 | −218 | −233 | −273 | −100 |
| EBIT | 6 042 | 5 730 | 3 072 | 5 997 | 6 143 |
| Net financials | −13 | 84 | −1 814 | −550 | 1 491 |
| Profit before tax | 4 514 | 4 348 | 2 153 | 4 079 | 5 845 |
| Tax | −973 | −940 | −823 | −1 030 | −703 |
| Net profit | 3 541 | 3 408 | 1 330 | 3 049 | 5 142 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 789 | 13 363 | 13 612 | 12 900 | 16 978 |
| Equity | 4 775 | 7 283 | 7 384 | 5 233 | 7 375 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 915 | 2 515 | 1 829 | 1 122 | 1 267 |
| Total debt | 1 915 | 2 515 | 1 829 | 1 122 | 1 267 |
EBITDA margin
36.9%
This company
15.8%
Market median
+134% vs market
20202024
Equity ratio
43.4%
This company
38.2%
Market median
+14% vs market
20202024
Return on equity
69.7%
This company
18.4%
Market median
+279% vs market
20202024
Net profit margin
30.4%
This company
8.1%
Market median
+275% vs market
20202024
Asset turnover
1.00×
This company
1.12×
Market median
+11% vs market
20202024
Debt / equity
1.30×
This company
0.62×
Market median
-110% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KB Chief Executive Officer | Chief Executive Officer | 2021 |
MH Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 |
| Audit | 2022 | |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VM79 hälsa och sjukvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Bertil Daniel Silvnäs | Chief Executive Officer | 0 companies |
| Maria Helena Silvnäs | Deputy Chief Executive Officer | 0 companies |
| David Ronnie Andreas Stefansson | Audit | 0 companies |